Abstract

Internal Medicine JournalVolume 50, Issue 9 p. 1153-1154 Letter to the Editor COVID-19 and chronic obstructive pulmonary disease: therapeutic potential of blocking SARS-CoV2 adhesion factors Shakti D. Shukla, Shakti D. Shukla orcid.org/0000-0002-5796-0171 Faculty of Health and Medicine, School of Medicine and Public Health, and Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, New South Wales, Australia Hunter Medical Research Institute, Newcastle, New South Wales, AustraliaSearch for more papers by this authorE. Haydn Walters, Corresponding Author E. Haydn Walters [email protected] College of Health and Medicine, University of Tasmania, Hobart, Tasmania, AustraliaSearch for more papers by this author Shakti D. Shukla, Shakti D. Shukla orcid.org/0000-0002-5796-0171 Faculty of Health and Medicine, School of Medicine and Public Health, and Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, New South Wales, Australia Hunter Medical Research Institute, Newcastle, New South Wales, AustraliaSearch for more papers by this authorE. Haydn Walters, Corresponding Author E. Haydn Walters [email protected] College of Health and Medicine, University of Tasmania, Hobart, Tasmania, AustraliaSearch for more papers by this author First published: 14 July 2020 https://doi.org/10.1111/imj.14887Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. Volume50, Issue9September 2020Pages 1153-1154 This article also appears in:Internal Medicine Journal’s COVID-19 Series RelatedInformation

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call